What’s new in insomnia? Diagnosis and treatment
ABSTRACT Although, insomnia is one of the most common diseases that health professionals face in their practice, it receives little attention in medical training. Diagnosis is based on a careful history taking, and physicians must be aware of the diagnostic criteria. Insomnia should not be considere...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia Brasileira de Neurologia (ABNEURO)
2022-08-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700307&tlng=en |
| _version_ | 1798037106156634112 |
|---|---|
| author | Álvaro Pentagna Luiz Henrique Martins Castro Bárbara Araújo Conway |
| author_facet | Álvaro Pentagna Luiz Henrique Martins Castro Bárbara Araújo Conway |
| author_sort | Álvaro Pentagna |
| collection | DOAJ |
| description | ABSTRACT Although, insomnia is one of the most common diseases that health professionals face in their practice, it receives little attention in medical training. Diagnosis is based on a careful history taking, and physicians must be aware of the diagnostic criteria. Insomnia should not be considered a symptom, but a comorbid condition. Although cognitive behavioral therapy (CBT) has been the mainstay treatment for insomnia for many years, it is usually regarded as a novel therapeutic strategy, both because of scarcity of qualified psychologists and of limited knowledge about insomnia among physicians. GABA receptor acting drugs are being abandoned in the treatment of insomnia because of abuse and dependence potential and accident risk. Two main current therapeutic options with the best scientific evidence are the tricyclic antidepressant, doxepin, and a new melatoninergic receptor agonist, ramelteon. Newer drugs to treat insomnia are in the pipeline. Hypocretine blocking agents will be marketed in the near future. |
| first_indexed | 2024-04-11T21:22:04Z |
| format | Article |
| id | doaj.art-3c30ec71b3bb4cd5ab21faa306a962f3 |
| institution | Directory Open Access Journal |
| issn | 1678-4227 |
| language | English |
| last_indexed | 2024-04-11T21:22:04Z |
| publishDate | 2022-08-01 |
| publisher | Academia Brasileira de Neurologia (ABNEURO) |
| record_format | Article |
| series | Arquivos de Neuro-Psiquiatria |
| spelling | doaj.art-3c30ec71b3bb4cd5ab21faa306a962f32022-12-22T04:02:35ZengAcademia Brasileira de Neurologia (ABNEURO)Arquivos de Neuro-Psiquiatria1678-42272022-08-01805 suppl 130731210.1590/0004-282x-anp-2022-s124What’s new in insomnia? Diagnosis and treatmentÁlvaro Pentagnahttps://orcid.org/0000-0001-9976-0787Luiz Henrique Martins Castrohttps://orcid.org/0000-0003-1878-8548Bárbara Araújo Conwayhttps://orcid.org/0000-0003-4162-0970ABSTRACT Although, insomnia is one of the most common diseases that health professionals face in their practice, it receives little attention in medical training. Diagnosis is based on a careful history taking, and physicians must be aware of the diagnostic criteria. Insomnia should not be considered a symptom, but a comorbid condition. Although cognitive behavioral therapy (CBT) has been the mainstay treatment for insomnia for many years, it is usually regarded as a novel therapeutic strategy, both because of scarcity of qualified psychologists and of limited knowledge about insomnia among physicians. GABA receptor acting drugs are being abandoned in the treatment of insomnia because of abuse and dependence potential and accident risk. Two main current therapeutic options with the best scientific evidence are the tricyclic antidepressant, doxepin, and a new melatoninergic receptor agonist, ramelteon. Newer drugs to treat insomnia are in the pipeline. Hypocretine blocking agents will be marketed in the near future.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700307&tlng=enSleep Initiation and Maintenance DisordersCognitive Behavioral TherapyHypnotics and Sedatives |
| spellingShingle | Álvaro Pentagna Luiz Henrique Martins Castro Bárbara Araújo Conway What’s new in insomnia? Diagnosis and treatment Arquivos de Neuro-Psiquiatria Sleep Initiation and Maintenance Disorders Cognitive Behavioral Therapy Hypnotics and Sedatives |
| title | What’s new in insomnia? Diagnosis and treatment |
| title_full | What’s new in insomnia? Diagnosis and treatment |
| title_fullStr | What’s new in insomnia? Diagnosis and treatment |
| title_full_unstemmed | What’s new in insomnia? Diagnosis and treatment |
| title_short | What’s new in insomnia? Diagnosis and treatment |
| title_sort | what s new in insomnia diagnosis and treatment |
| topic | Sleep Initiation and Maintenance Disorders Cognitive Behavioral Therapy Hypnotics and Sedatives |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2022000700307&tlng=en |
| work_keys_str_mv | AT alvaropentagna whatsnewininsomniadiagnosisandtreatment AT luizhenriquemartinscastro whatsnewininsomniadiagnosisandtreatment AT barbaraaraujoconway whatsnewininsomniadiagnosisandtreatment |